4 Cervical Cancer Screening Related Publications
4.1 Peer-Reviewed Publications
4.2 Non-Peer Reviewed Publications
4.1 Peer-Reviewed Publications
Wright TC, Schiffman M, Solomon D, Cox JT et.al.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening.
Obstetrics and Gynecology February 2004. Vol 103(2):304-309.
Wright TC, Cox JT, Massad S, Carlson J, Twiggs LB, Wilinson EJ.
2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia.
Am J Obstet Gynecol. 2003 July; 189 (1): 295-304.
Davey DD., Austin RM., Birdsong G., Buck HW., Cox JT., et al.
ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators.
Am J. Clin. Pahol. 2002 Nov;118(5):714-8
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur, D, Wright T, Young.
The 2001 Bethesda System, Terminology for Reporting Results of Cervical Cytology.
JAMA, April 24, 2002. Vol 287(16): 2114-2119.
Stoler M.
New Bethesda Terminology and Evidence Based Management Guidelines for Cervical Cytology Findings.
JAMA, April 24, 2002. Vol 287(16): 2140-2141.
Davey DD, Austin RM, Birdsong G, Buck HW, Cox JT, Darragh TM, Elgert PA, Hanson V, Henry MR, Waldman J; American Society for Colposcopy and Cervical Pathology.
ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
Am J Clin Pathol. 2002 Nov;118(5):714-8.
Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C.
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer.
CA Cancer J Clin. Nov/Dec 2002. Vol 52(6): 375-376.
Wright T, Cox JT, Massad LS, Twiggs L, Wilkinson E for the 2001 ASCCP-Sponsored Consensus Conference.
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities.
JAMA, April 24, 2000. Vol 287(16): 2120-2129.
Back to top
4.2 Non-peer Reviewed Publications
Agency for Health Care Research and Quality. Report of the US Preventive Services Task Force.
Recommendations and Rationale, Screening for Cervical Cancer.
Guide to Clinical Preventative Services, 3rd Edition 2002-2003.
http://www.preventiveservices.ahrq.gov, National Guideline Clearinghouse www.guideline.gov, AHRQ Publications Clearinghouse - 1.800.358.9295 or ahrqpubs@ahrq.gov.
Lazcano-Ponce E., Alonso P., Ruiz-Moreno JA., Hernandez-Avila M.
Recommendations for Cervical Cancer Screening Programs in Developing Countries. The Need for Equity and Technological Development.
Salud Publica de Mexico 2003. Vol 45(3);449-462.
Frable WJ., Vooijs GP., Henry MR., Bonfiglio TA,, Wilbur DC., Lee JSJ.
A Tribute to Stanley F. Patten, Jr.,M.D.,Ph.D.
December 1997.Vol 81(6);315-336.
Solomon D., Nayar R.
The Bethesda System for Reporting Cervical Cytology.
2004. Springer-Verlag. NY, NY.
